Therapeutic and Diagnostic Startups
U-M has a rich history of discovering compounds that lead to FDA approved treatments. An analysis by “Drug Discovery Today” found that U-M is the largest single contributor among academic institutions in creating FDA approved new molecular entities.
Due to the strength and importance of patent rights for therapeutic and diagnostic licenses, U-M will offer a license that reflects fair market value terms for up-front payment, royalties, clinical and commercial milestone payments and equity. These terms will differ based upon the indication pursued and the stage of the technology. Our licensing professionals will work with you to develop a license agreement with terms that are compatible with raising venture capital and successful commercialization.